FEZF1 and renal cell carcinoma: Through bioinformatics prediction, it was found that FEZF1-AS1 can base pair complementary with the 3'-UTR of ETNK1, thus we speculate that it may affect the expression of ETNK1, thereby promoting the malignant development of RCC.